Diampa L XR 25/5/1000mg Tablet – Triple Action Type 2 Diabetes Control with Empagliflozin, Linagliptin & Metformin
Diampa L XR 25/5/1000mg Tablet – Triple Action Type 2 Diabetes Control with Empagliflozin, Linagliptin & Metformin
Diampa L XR 25/5/1000mg Tablet – Triple Action Type 2 Diabetes Control with Empagliflozin, Linagliptin & Metformin
Description
Diampa L XR 25/5/1000mg Tablet – Complete Once-Daily Therapy for Superior Blood Sugar Management
Diampa L XR 25/5/1000mg Tablet combines three powerful anti-diabetic agents – Empagliflozin 25mg (SGLT2 inhibitor), Linagliptin 5mg (DPP-4 inhibitor), and Metformin XR 1000mg (biguanide) – in a single extended-release tablet. This triple combination works through complementary mechanisms to deliver robust HbA1c reduction, promote urinary glucose excretion, enhance insulin secretion, and improve insulin sensitivity. Ideal for patients with inadequate control on dual therapy, it offers added cardiovascular and kidney protection along with convenient once-daily dosing.
